These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25225751)

  • 41. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
    Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
    J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ferritin Decorated PLGA/Paclitaxel Loaded Nanoparticles Endowed with an Enhanced Toxicity Toward MCF-7 Breast Tumor Cells.
    Turino LN; Ruggiero MR; Stefanìa R; Cutrin JC; Aime S; Geninatti Crich S
    Bioconjug Chem; 2017 Apr; 28(4):1283-1290. PubMed ID: 28301933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
    Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
    Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
    Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
    J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucosylated polymeric nanoparticles: a sweetened approach against blood compatibility paradox.
    Thasneem YM; Sajeesh S; Sharma CP
    Colloids Surf B Biointerfaces; 2013 Aug; 108():337-44. PubMed ID: 23563302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-VEGFR2-conjugated PLGA microspheres as an x-ray phase contrast agent for assessing the VEGFR2 expression.
    Tang R; Chai WM; Ying W; Yang GY; Xie H; Liu HQ; Chen KM
    Phys Med Biol; 2012 May; 57(10):3051-63. PubMed ID: 22538445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, characterization, and in vitro evaluation of targeted gold nanoshelled poly(d,l-lactide-co-glycolide) nanoparticles carrying anti p53 antibody as a theranostic agent for ultrasound contrast imaging and photothermal therapy.
    Xu L; Wan C; Du J; Li H; Liu X; Yang H; Li F
    J Biomater Sci Polym Ed; 2017 Mar; 28(4):415-430. PubMed ID: 28044473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
    Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
    Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
    Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
    Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PLGA nanoparticles from nano-emulsion templating as imaging agents: Versatile technology to obtain nanoparticles loaded with fluorescent dyes.
    Fornaguera C; Feiner-Gracia N; Calderó G; García-Celma MJ; Solans C
    Colloids Surf B Biointerfaces; 2016 Nov; 147():201-209. PubMed ID: 27513588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Theranostic poly(lactic-co-glycolic acid) nanoparticle for magnetic resonance/infrared fluorescence bimodal imaging and efficient siRNA delivery to macrophages and its evaluation in a kidney injury model.
    Yang C; Vu-Quang H; Husum DMU; Tingskov SJ; Vinding MS; Nielsen T; Song P; Nielsen NC; Nørregaard R; Kjems J
    Nanomedicine; 2017 Nov; 13(8):2451-2462. PubMed ID: 28842376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus.
    Zhang Y; Zhou J; Guo D; Ao M; Zheng Y; Wang Z
    Int J Nanomedicine; 2013; 8():3745-56. PubMed ID: 24124363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting.
    Alberti D; Protti N; Franck M; Stefania R; Bortolussi S; Altieri S; Deagostino A; Aime S; Geninatti Crich S
    ChemMedChem; 2017 Apr; 12(7):502-509. PubMed ID: 28217982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Poly(lactic-co-glycolic acid) matrix incorporated with nisin as a novel antimicrobial biomaterial.
    Correia RC; Jozala AF; Martins KF; Penna TC; Duek EA; Rangel-Yagui Cde O; Lopes AM
    World J Microbiol Biotechnol; 2015 Apr; 31(4):649-59. PubMed ID: 25677652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.